Healthcare -
Biotechnology - NASDAQ - US
$ 28.87
0.698 %
$ 3.24 B
Market Cap
-28.58
P/E
VKTX - TOTAL CURRENT LIABILITIES
Total Current Liabilities VKTX - Viking Therapeutics, Inc.
19.1 M
LAST VALUE
47.64%
2 YEAR CAGR
33.28%
5 YEAR CAGR
65.06%
10 YEAR CAGR